Literature DB >> 17287239

Focal cortical dysplasia: long term seizure outcome after surgical treatment.

T Kral1, M von Lehe, M Podlogar, H Clusmann, P Süssmann, M Kurthen, A Becker, H Urbach, J Schramm.   

Abstract

BACKGROUND: Studies of long term outcome after epilepsy surgery for cortical malformations are rare. In this study, we report our experience with surgical treatment and year to year long term outcome for a subgroup of patients with focal cortical dysplasia (FCD).
METHODS: We retrospectively analysed the records of 49 patients (females n = 26; males n = 23; mean age 25 (11) years) with a mean duration of epilepsy of 18 years (range 1-45). Preoperative MRI, histological results based on the Palmini classification and clinical year to year follow-up according to the International League Against Epilepsy (ILAE) classification were available in all patients.
RESULTS: 98% of patients had a lesion on preoperative MRI. In addition to lobectomy (n = 9) or lesionectomy (n = 40), 14 patients had multiple subpial transections of the eloquent cortex. The resected tissue was classified as FCD type II b in 41 cases with an extratemporal (88%) and FCD type II a in 8 cases with a temporal localisation (100%). After a mean follow-up of 8.1 (4.5) years, 37 patients (76%) were seizure free, a subgroup of 23 patients (47%) had been completely seizure free since surgery (ILAE class 1a) and 4 patients (8%) had only auras (ILAE class 2). Over a 10 year follow-up, the proportion of satisfactory outcomes decreased, mainly within the first 3 years. During long term follow-up, 48% stopped antiepileptic drug treatment, 34% received a driver's license and 57% found a job or training.
CONCLUSION: Surgical treatment of epilepsy with FCD is not only successful in the short term but also has a satisfying long term outcome which remains constant after 3 years of follow-up but is not associated with better employment status or improvement in daily living.

Entities:  

Mesh:

Year:  2007        PMID: 17287239      PMCID: PMC2117728          DOI: 10.1136/jnnp.2006.105361

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy.

Authors:  Nadia Colombo; Laura Tassi; Carlo Galli; Alberto Citterio; Giorgio Lo Russo; Giuseppe Scialfa; Roberto Spreafico
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

2.  Long-term outcome after temporal lobe surgery--prediction of late worsening of seizure control.

Authors:  Anna Kelemen; Péter Barsi; Lóránd Eross; János Vajda; Sándor Czirják; Csaba Borbély; György Rásonyi; Péter Halász
Journal:  Seizure       Date:  2005-12-20       Impact factor: 3.184

3.  Surgical treatment of intractable epilepsy accompanying cortical dysplasia.

Authors:  S C Hong; K S Kang; D W Seo; S B Hong; M Lee; D H Nam; J I Lee; J S Kim; H J Shin; K Park; W Eoh; Y L Suh; J H Kim
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

Review 4.  Preoperative evaluation for epilepsy surgery (Bonn Algorithm).

Authors:  T Kral; H Clusmann; J Urbach; J Schramm; C E Elger; M Kurthen; T Grunwald
Journal:  Zentralbl Neurochir       Date:  2002

5.  Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome.

Authors:  Horst Urbach; Björn Scheffler; Thomas Heinrichsmeier; Joachim von Oertzen; Thomas Kral; Joerg Wellmer; Johannes Schramm; Otmar D Wiestler; Ingmar Blümcke
Journal:  Epilepsia       Date:  2002-01       Impact factor: 5.864

6.  Outcome of epilepsy surgery in focal cortical dysplasia.

Authors:  T Kral; H Clusmann; I Blümcke; R Fimmers; B Ostertun; M Kurthen; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

7.  Long-term seizure outcome in patients initially seizure-free after resective epilepsy surgery.

Authors:  H H Yoon; H L Kwon; R H Mattson; D D Spencer; S S Spencer
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

8.  Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features.

Authors:  Jocelyn F Bautista; Nancy Foldvary-Schaefer; William E Bingaman; Hans O Lüders
Journal:  Epilepsy Res       Date:  2003 Jun-Jul       Impact factor: 3.045

9.  Long-term psychosocial outcomes of anterior temporal lobectomy.

Authors:  Jana E Jones; Norman L Berven; Lincoln Ramirez; Austin Woodard; Bruce P Hermann
Journal:  Epilepsia       Date:  2002-08       Impact factor: 5.864

10.  Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients.

Authors:  L Jutila; A Immonen; E Mervaala; J Partanen; K Partanen; M Puranen; R Kälviäinen; I Alafuzoff; H Hurskainen; M Vapalahti; A Ylinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

View more
  13 in total

1.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

2.  A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia.

Authors:  Bo Jin; Jing Wang; Jian Zhou; Shuang Wang; Yuguang Guan; Shuhua Chen
Journal:  J Neurol       Date:  2016-09-08       Impact factor: 4.849

3.  Voxel-based morphometric MRI post-processing in MRI-negative focal cortical dysplasia followed by simultaneously recorded MEG and stereo-EEG.

Authors:  Z I Wang; S E Jones; A J Ristic; C Wong; Y Kakisaka; K Jin; F Schneider; J A Gonzalez-Martinez; J C Mosher; D Nair; R C Burgess; I M Najm; A V Alexopoulos
Journal:  Epilepsy Res       Date:  2012-03-04       Impact factor: 3.045

4.  Type II focal cortical dysplasia: electroclinical study and surgical outcome in 31 pediatric patients.

Authors:  Daniel Noli; Marcelo Bartuluchi; Federico Sanchez González; María Carolina Kaltenmeier; Ricardo Cersosimo; Carlos Rugilo; Juan P Princich; Fabiana Lubieniecki; Hugo Pomata; Roberto Caraballo
Journal:  Childs Nerv Syst       Date:  2013-07-07       Impact factor: 1.475

5.  The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia.

Authors:  A Simon Harvey; Simone A Mandelstam; Wirginia J Maixner; Richard J Leventer; Mira Semmelroch; Duncan MacGregor; Renate M Kalnins; Yuliya Perchyonok; Gregory J Fitt; Sarah Barton; Michael J Kean; Gavin C A Fabinyi; Graeme D Jackson
Journal:  Neurology       Date:  2015-04-17       Impact factor: 9.910

6.  Focal Cortical Dysplasia and Refractory Epilepsy: Role of Multimodality Imaging and Outcome of Surgery.

Authors:  S Jayalakshmi; S K Nanda; S Vooturi; R Vadapalli; P Sudhakar; S Madigubba; M Panigrahi
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-18       Impact factor: 3.825

7.  Seizure Freedom in Children With Pathology-Confirmed Focal Cortical Dysplasia.

Authors:  Anna Mrelashvili; Robert J Witte; Elaine C Wirrell; Katherine C Nickels; Lily C Wong-Kisiel
Journal:  Pediatr Neurol       Date:  2015-09-12       Impact factor: 3.372

8.  [Quality of life following extratemporal epilepsy surgery].

Authors:  A Schulze-Bonhage; B Metternich; S Biethahn; J Zentner; K Wagner
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

9.  FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy.

Authors:  N Salamon; J Kung; S J Shaw; J Koo; S Koh; J Y Wu; J T Lerner; R Sankar; W D Shields; J Engel; I Fried; H Miyata; W H Yong; H V Vinters; G W Mathern
Journal:  Neurology       Date:  2008-11-11       Impact factor: 9.910

10.  Post-Surgical Outcome and Its Determining Factors in Patients Operated on With Focal Cortical Dysplasia Type II-A Retrospective Monocenter Study.

Authors:  Attila Rácz; Albert J Becker; Carlos M Quesada; Valeri Borger; Hartmut Vatter; Rainer Surges; Christian E Elger
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.